Clinical pilot study of a cytotoxic antiserum in myeloblastic leukemia.
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged
D000961:Antilymphocyte Serum; D003176:Complement C3; D003181:Complement C4